Therefore, ADT when used in combination with either AR inhibitors or luteinizing hormone-releasing hormone modulators could potentially act as a propylactic therapy used as an interceptive medicine against COVID-19 patients who are suffering from a high risk of the disease [100]. The gene discussed is AR; the disease is COVID-19.